
GHK-Cu · 100 mg
A naturally occurring copper-binding tripeptide. Levels in human plasma fall by roughly 60% between age 20 and 60 — which is the whole premise behind using it.
Includes 10× sterile insulin syringes + 1 vial of bacteriostatic water, free with your order.
Complete your kit
For research and educational use only. Not for human or veterinary consumption.
- Collagen production — the best-documented effect, and the reason it appears in serious skincare
- Skin texture and firmness improve gradually over 8–12 weeks
- Fine lines soften
- Wound healing support
- Hair follicle support — widely used topically for thinning
- Anti-inflammatory and antioxidant activity
It does not tighten loose or sagging skin. This is the most common wrong expectation. GHK-Cu improves collagen quality, not skin laxity. If sagging is the actual problem, a laser or a surgeon is the honest answer and we'd rather say so before you spend the money.
It does not work fast. Give it 8–12 weeks minimum before judging.
The strong human evidence is for topical use, not injection. There is no published human trial of injectable GHK-Cu for skin, hair or wound outcomes.
Expected and normal: the solution turns blue-green. That's the copper. Not contamination. Common: injection site reactions, sometimes more noticeable than other peptides. Important handling: keep GHK-Cu in its own dedicated cartridge. Never share a cartridge with another compound. Theoretical: free copper is toxic at high load. At community injectable doses this is not documented as a problem, but it's a real reason not to escalate.
Draw past the line, tap out bubbles, push back to the line.
The AVERON Peptide Pen delivers 1 click = 0.01 mL. A U-100 insulin syringe delivers 1 unit = 0.01 mL. They are the same number. 20 clicks on the pen and 20 units on a syringe deliver exactly the same dose.
Maximum per injection: 100 units (1 mL)
100 mg vial + 3 mL bacteriostatic water = 33.3 mg/mL
| Dose | Volume | Units (U-100) |
|---|---|---|
| 1 mg | 0.03 mL | 3 |
| 2 mg | 0.06 mL | 6 |
Expect the blue-green colour immediately on mixing.
Draw past the line, tap out bubbles, push back to the line.
The AVERON Peptide Pen delivers 1 click = 0.01 mL. A U-100 insulin syringe delivers 1 unit = 0.01 mL. They are the same number. 20 clicks on the pen and 20 units on a syringe deliver exactly the same dose.
Maximum per injection: 100 units (1 mL)
2 mg daily, subcutaneous. Community range is 1–2 mg/day.
Cycle: 8–12 weeks. One vial covers 50 days of material, but the 4-week refrigerated window is the real limit — you will not finish a vial. That's inherent to the format, not waste you can avoid.
Contraindicated in Wilson's disease or any copper overload condition.
- 1× GHK-Cu · 100 mg
- 10× sterile insulin syringes (free)
- 1× bacteriostatic water vial (free)
- Compound Guide — printed, included free
Topical GHK-Cu has genuine human data — a 2002 photoaging study, and a 2023 study reporting roughly 28% increased collagen density at three months. Injectable GHK-Cu has none of that. Its use by injection is a community practice extrapolated from topical results. Patent literature even questions subcutaneous suitability on copper-toxicity grounds. Topical copper-tripeptide is an established cosmetic ingredient; injectable is not approved anywhere.
Every peptide batch we sell is tested by Janoshik Analytical, an independent laboratory. Every vial carries an internal AVERON batch code identifying the lot received; each lot is linked to its published Janoshik report. The report carries the manufacturer's submission/task number, not the AVERON code. Ask us or our driver which report covers your code and open it on the laboratory's own website before paying. In our own-driver zone, the team shows you the vial and the report for that batch before payment.
A lab report handed to you by a seller and a lab report you can verify yourself are not the same thing. That's why we publish ours.
View COA on Janoshik







